These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 26900407)

  • 1. Fibronectin Mechanobiology Regulates Tumorigenesis.
    Wang K; Seo BR; Fischbach C; Gourdon D
    Cell Mol Bioeng; 2016; 9():1-11. PubMed ID: 26900407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fibronectin as an active component of the extracellular matrix].
    Krzyzanowska-Gołab D; Lemańska-Perek A; Katnik-Prastowska I
    Postepy Hig Med Dosw (Online); 2007 Nov; 61():655-63. PubMed ID: 17989620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shaping Up the Tumor Microenvironment With Cellular Fibronectin.
    Efthymiou G; Saint A; Ruff M; Rekad Z; Ciais D; Van Obberghen-Schilling E
    Front Oncol; 2020; 10():641. PubMed ID: 32426283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Force-induced unfolding of fibronectin in the extracellular matrix of living cells.
    Smith ML; Gourdon D; Little WC; Kubow KE; Eguiluz RA; Luna-Morris S; Vogel V
    PLoS Biol; 2007 Oct; 5(10):e268. PubMed ID: 17914904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TLR4 agonist fibronectin extra domain A is cryptic, exposed by elastase-2; use in a fibrin matrix cancer vaccine.
    Julier Z; Martino MM; de Titta A; Jeanbart L; Hubbell JA
    Sci Rep; 2015 Feb; 5():8569. PubMed ID: 25708982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stretch-dependent changes in molecular conformation in fibronectin nanofibers.
    Szymanski JM; Sevcik EN; Zhang K; Feinberg AW
    Biomater Sci; 2017 Jul; 5(8):1629-1639. PubMed ID: 28612067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced conformational changes of fibronectin within the extracellular matrix promote hMSC osteogenic differentiation.
    Li B; Lin Z; Mitsi M; Zhang Y; Vogel V
    Biomater Sci; 2015 Jan; 3(1):73-84. PubMed ID: 26214191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism.
    Wijelath ES; Rahman S; Namekata M; Murray J; Nishimura T; Mostafavi-Pour Z; Patel Y; Suda Y; Humphries MJ; Sobel M
    Circ Res; 2006 Oct; 99(8):853-60. PubMed ID: 17008606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer cells alter the dynamics of stromal fibronectin-collagen interactions.
    Wang K; Wu F; Seo BR; Fischbach C; Chen W; Hsu L; Gourdon D
    Matrix Biol; 2017 Jul; 60-61():86-95. PubMed ID: 27503584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiscale relationships between fibronectin structure and functional properties.
    Bradshaw MJ; Smith ML
    Acta Biomater; 2014 Apr; 10(4):1524-31. PubMed ID: 23978411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction with heparin and matrix metalloproteinase 2 cleavage expose a cryptic anti-adhesive site of fibronectin.
    Watanabe K; Takahashi H; Habu Y; Kamiya-Kubushiro N; Kamiya S; Nakamura H; Yajima H; Ishii T; Katayama T; Miyazaki K; Fukai F
    Biochemistry; 2000 Jun; 39(24):7138-44. PubMed ID: 10852711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular matrix fibronectin initiates endothelium-dependent arteriolar dilatation via the heparin-binding, matricryptic RWRPK sequence of the first type III repeat of fibrillar fibronectin.
    Sarelius IH; Titus PA; Maimon N; Okech W; Wilke-Mounts SJ; Brennan JR; Hocking DC
    J Physiol; 2016 Feb; 594(3):687-97. PubMed ID: 26661689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of material-driven fibronectin fibrillogenesis in cell differentiation.
    Salmerón-Sánchez M; Rico P; Moratal D; Lee TT; Schwarzbauer JE; García AJ
    Biomaterials; 2011 Mar; 32(8):2099-105. PubMed ID: 21185593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel fibronectin binding site required for fibronectin fibril growth during matrix assembly.
    Sechler JL; Rao H; Cumiskey AM; Vega-Colón I; Smith MS; Murata T; Schwarzbauer JE
    J Cell Biol; 2001 Sep; 154(5):1081-8. PubMed ID: 11535624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of mechanical and binding properties of Fibronectin type I.
    Diao J; Maniotis AJ; Folberg R; Tajkhorshid E
    Theor Chem Acc; 2010 May; 125(3-6):397-405. PubMed ID: 20824113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human fibronectin and MMP-2 collagen binding domains compete for collagen binding sites and modify cellular activation of MMP-2.
    Steffensen B; Xu X; Martin PA; Zardeneta G
    Matrix Biol; 2002 Aug; 21(5):399-414. PubMed ID: 12225805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiadhesive sites present in the fibronectin type III-like repeats of human plasma fibronectin.
    Miura S; Kamiya S; Saito Y; Wada S; Hayashi R; Taira J; Kodama H; Yajima H; Ueki M; Fukai F
    Biol Pharm Bull; 2007 May; 30(5):891-7. PubMed ID: 17473431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts.
    Tremble P; Chiquet-Ehrismann R; Werb Z
    Mol Biol Cell; 1994 Apr; 5(4):439-53. PubMed ID: 7519905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Cryptic Binding Sites are Necessary for Robust Fibronectin Assembly: An In Silico Study.
    Lemmon CA; Weinberg SH
    Sci Rep; 2017 Dec; 7(1):18061. PubMed ID: 29273802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin and its soluble EDA-FN isoform as biomarkers for inflammation and sepsis.
    Lemańska-Perek A; Adamik B
    Adv Clin Exp Med; 2019 Nov; 28(11):1561-1567. PubMed ID: 31596557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.